Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

U.S. to detail global distribution plan for 80 million vaccine doses

Published 06/01/2021, 08:49 PM
Updated 06/02/2021, 11:41 AM
© Reuters. U.S. Secretary of State Antony Blinken attends a meeting with the foreign ministers of Mexico and Central American Integration System (SICA) member states at Intercontinental Hotel Costa Rica, in San Jose, Costa Rica June 1, 2021. REUTERS/Evelyn Hockstein

By Humeyra Pamuk

SAN JOSE, Costa Rica (Reuters) -The United States will announce in the next two weeks how it plans to distribute 80 million COVID-19 vaccine doses it has pledged globally, U.S. Secretary of State Antony Blinken said on Tuesday.

Speaking at a joint news conference with Costa Rican President Carlos Alvarado, Blinken said the administration of U.S. President Joe Biden would focus on equitable distribution of the vaccines and not tie political strings to the process, a criticism at times directed at China.

"Sometime in the next week to two weeks – we will be announcing the process by which we will distribute those vaccines, what the criteria are, how we will do it," Blinken said during his first trip as secretary of state to Latin America, which is fighting to contain COVID-19.

"We will distribute vaccines without political requirements of those receiving them."

On Monday, Biden said his administration would send at least 20 million doses of the Pfizer (NYSE:PFE) Inc/BioNTech SE, Moderna (NASDAQ:MRNA) Inc and Johnson & Johnson (NYSE:JNJ) vaccines, on top of 60 million AstraZeneca (NASDAQ:AZN) Plc doses he had already planned to give to other countries.

The Biden administration has been under pressure to share vaccines to help curb worsening outbreaks from India to Brazil, where health experts fear new, more contagious coronavirus variants could undermine the effectiveness of available shots.

Blinken said the announcement would reveal the criteria and details of the process but that the United States would focus on the equitable distribution and work in coordination of the COVAX vaccine sharing facility.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

As the pandemic outlook within the United States brightens with advancing vaccinations, the aid pledge is central to the administration's drive to use U.S. vaccine supply as a tool to counter Chinese and Russian vaccine diplomacy.

A senior State Department official, when asked if the United States during this trip made vaccine commitments, to Central America or Costa Rica specifically, said no region or country specific pledges had been made.

"We don't know what the final distribution is going to be. A lot of it has to do with essentially epidemiology and where the science says that we should be dedicating those vaccines to prevent further spread," the official told reporters in a briefing.

Biden, who has loaned some unused vaccines to Canada and Mexico and donated funds to a multilateral vaccination effort for poor countries, in April said the White House was still looking at its options for eventually sending vaccines to Canada, Central America and elsewhere.

Costa Rica's Alvarado stressed that his country was hoping for prompt news on vaccine distribution.

Earlier on Tuesday, the World Bank urged the United States to free up excess vaccines.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.